HENDERSON JOHN T bought CYTK
July 15, 2025 · Form 4 insider transaction
HENDERSON JOHN T bought 559 shares of Cytokinetics, Incorporated at $38.01 per share, a transaction worth $21.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
559
Price
$38.01
Total value
$21.2K
InsiderHENDERSON JOHN T
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 15, 2025
Filing dateJuly 16, 2025
Shares owned after74,240
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Director equity in lieu of cash retainer program.